Third Rock Ventures
About Third Rock Ventures
Third Rock Ventures invests in transformational life science companies that show high growth potential
Investment focus
Stages
Sectors
Portfolio (6 in our database)
Goldfinch BiopharmaGoldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.Series B · $210M raisedAmbys MedicinesAmbys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.Series A · $187M raisedElement ScienceElement Science is a medical device and digital health start-up that develops lifesaving wearable solutions.Series C · $183M raisedCedilla TherapeuticsCedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.Series B · $139M raisedCasma TherapeuticsCasma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.Series B · $109M raisedAbata TherapeuticsAbata Therapeutics is a biotech company focused on translating the biology of regulatory T cells (Tregs) into transformational medicine.Series A · $95M raised